| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |